Kristopher T. Kahle, M.D., Ph.D., is the Nicholas T. Zervas Associate Professor of Neurosurgery at Harvard Medical School (HMS), Chief of Pediatric Neurosurgery at the Massachusetts General Hospital (MGH), and Director of the MGH Hydrocephalus and Neurodevelopmental Disorders Program. He is an Investigator in the Division of Genetics and Genomics at Boston Children’s Hospital (BCH) and an Associate Member of the Broad Institute. He is a board-certified pediatric neurosurgeon who specializes in the treatment of congenital anomalies of the nervous system in patients across the age spectrum. Dr. Kahle is a fellow of the American Association of Neurological Surgeons, Congress of Neurological Surgeons, American Society of Pediatric Neurosurgeons, and International Society of Pediatric Neurosurgeons. Dr. Kahle is a principal investigator with three active primary NIH RO1 grants whose lab studies the genomics and mechanisms of the disorders he treats in the operating room, with a special interest in CSF disorders. Dr. Kahle graduated from the University of Chicago in 1999 with degrees in Biology and Philosophy. He received his M.D. from Yale School of Medicine in 2007, where he also received his Ph.D. working in the laboratory of human geneticist Richard Lifton. He completed his neurosurgery residency training at MGH in 2014, as well as a post-doctoral research fellowship at Harvard University with adviser Stephen Elledge. He completed a clinical pediatric neurosurgery fellowship at BCH, where he was Shellito staff associate and Instructor of Neurosurgery at HMS. Dr. Kahle returned to New Haven to join the Yale faculty, where he was Assistant Professor of Neurosurgery, Pediatrics, and Cellular & Molecular Physiology, and Director of Neonatal and Congenital Anomaly Neurosurgery from 2016-2021.